No abstract available
Publication types
-
Consensus Development Conference
-
Practice Guideline
MeSH terms
-
Adrenal Cortex Hormones / therapeutic use*
-
Adult
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Murine-Derived
-
Autoantibodies / blood
-
Benzoates / adverse effects
-
Benzoates / therapeutic use
-
Blood Coagulation Tests
-
Blood Platelets / immunology
-
Blood Transfusion
-
Child
-
Cross-Sectional Studies
-
Diagnosis, Differential
-
Evidence-Based Medicine*
-
Germany
-
Hemorrhage / classification
-
Hemorrhage / etiology
-
Hospitalization
-
Humans
-
Hydrazines / adverse effects
-
Hydrazines / therapeutic use
-
Immunization, Passive*
-
Immunosuppressive Agents / therapeutic use*
-
Platelet Count
-
Purpura, Thrombocytopenic, Idiopathic / blood
-
Purpura, Thrombocytopenic, Idiopathic / diagnosis*
-
Purpura, Thrombocytopenic, Idiopathic / drug therapy*
-
Purpura, Thrombocytopenic, Idiopathic / etiology
-
Pyrazoles / adverse effects
-
Pyrazoles / therapeutic use
-
Receptors, Fc / therapeutic use
-
Receptors, Thrombopoietin / agonists*
-
Recombinant Fusion Proteins / adverse effects
-
Recombinant Fusion Proteins / therapeutic use
-
Recurrence
-
Rituximab
-
Splenectomy
-
Thrombopoietin / adverse effects
-
Thrombopoietin / therapeutic use
Substances
-
Adrenal Cortex Hormones
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Murine-Derived
-
Autoantibodies
-
Benzoates
-
Hydrazines
-
Immunosuppressive Agents
-
Pyrazoles
-
Receptors, Fc
-
Receptors, Thrombopoietin
-
Recombinant Fusion Proteins
-
MPL protein, human
-
Rituximab
-
Thrombopoietin
-
romiplostim
-
eltrombopag